{"id":3923,"date":"2023-01-04T17:05:34","date_gmt":"2023-01-04T17:05:34","guid":{"rendered":"https:\/\/regensight.com\/argo-clinical-trial-protocol\/"},"modified":"2023-01-04T17:05:34","modified_gmt":"2023-01-04T17:05:34","slug":"argo-clinical-trial-protocol","status":"publish","type":"post","link":"https:\/\/regensight.com\/en\/argo-clinical-trial-protocol\/","title":{"rendered":"ARGO clinical trial protocol"},"content":{"rendered":"<p>The ARGO clinical trial protocol has been published in the \u201cNew Treatments for Keratoconus\u201d Special Issue of International Ophthalmology.<\/p>\n<p>The publication is open access and available at <a href=\"https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02628-4\">https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02628-4<\/a>.<\/p>\n<p>The manuscript includes exhaustive information on the ARGO clinical trial design and research protocol, which is targeting to validate #theranostics for personalized and precision corneal cross-linking for treating keratoconus.<\/p>\n<p>Regensight is a startup Company committed in the dissemination of the clinical trial design for the benefit of the entire medical community and the patients they serve. This is a part of the ethical mandate, mission and vision statement of our Company.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The ARGO clinical trial protocol has been published in the \u201cNew Treatments for Keratoconus\u201d Special Issue of International Ophthalmology. The publication is open access and available at https:\/\/link.springer.com\/article\/10.1007\/s10792-022-02628-4. The manuscript includes exhaustive information on the ARGO clinical trial design and research protocol, which is targeting to validate #theranostics for personalized and precision corneal cross-linking for [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":3921,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":""},"categories":[35],"tags":[],"_links":{"self":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/3923"}],"collection":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/comments?post=3923"}],"version-history":[{"count":0,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/posts\/3923\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media\/3921"}],"wp:attachment":[{"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/media?parent=3923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/categories?post=3923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regensight.com\/en\/wp-json\/wp\/v2\/tags?post=3923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}